Arvinas ARVN
NASDAQ ARVN
$6.91 -0.01 (-0.14%)
At close: Nov 11, 2026 · 4:00 PM EST

Arvinas (ARVN) Shares Outstanding (Diluted) (2019 - 2026)

Updated

Arvinas (ARVN) posted Weighted Average Shares Outstanding (Diluted) of 65.4 million for Q3 2026, down 10.7% from 73.2 million a year earlier and down 0.5% from the prior quarter.

Analysis

Arvinas (ARVN) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends

For FY2025, Arvinas' Weighted Average Shares Outstanding (Diluted) came in at 70.9 million, down 1.4% from FY2024.

  • Annual Weighted Average Shares Outstanding (Diluted) shows a five-year compound annual growth rate of 12.4% (FY2020 to FY2025).
  • In prior years, Arvinas' Weighted Average Shares Outstanding (Diluted) was 71.9 million in FY2024 (+29.5%), 55.5 million in FY2023 (+4.3%), 53.2 million in FY2022 (+6.4%) and 50 million in FY2021 (+26.6%).
  • Quarterly Weighted Average Shares Outstanding (Diluted) has run from a low of 50 million in Q4 2021 to a high of 73.2 million in Q3 2025 over five years.
  • On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has declined in each of the last four quarters, with an average year-over-year change of 0.0% over the last eight quarters.
  • The strongest year-over-year quarter for Weighted Average Shares Outstanding (Diluted) in the past five years was Q2 2024, with growth of 34.6%; the weakest was Q1 2026, with a decline of 12.0%.
  • According to Business Quant data, Weighted Average Shares Outstanding (Diluted) for the three prior quarters was 65.7 million (Q2 2026), 64 million (Q1 2026) and 70.9 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.45 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.96 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.75 Bn
10 Arvinas 453.26 Mn -1.97 Bn 400,000.00 65.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 65.40 Mn
Jun 30, 2026 65.70 Mn
Mar 31, 2026 64.00 Mn
Dec 31, 2025 70.90 Mn
Sep 30, 2025 73.20 Mn
Jun 30, 2025 73.00 Mn
Mar 31, 2025 72.70 Mn
Dec 31, 2024 71.90 Mn
Sep 30, 2024 72.10 Mn
Jun 30, 2024 71.90 Mn
Mar 31, 2024 71.70 Mn
Dec 31, 2023 55.50 Mn
Sep 30, 2023 54.10 Mn
Jun 30, 2023 53.40 Mn
Mar 31, 2023 53.30 Mn
Dec 31, 2022 53.20 Mn
Sep 30, 2022 53.20 Mn
Jun 30, 2022 53.20 Mn
Mar 31, 2022 53.00 Mn
Dec 31, 2021 50.00 Mn
API Access

Arvinas Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ARVN&period=max&api_key=YOUR_API_KEY